|
|
Pharma R&D Partnering World Asia 2010
Pharma R&D Partnering World Asia 2010 will bring together international and regional pharmaceutical companies, start-up & spin-off biotechs, research and academic institutions, professional investors, contract research service providers to network and evaluate partnering opportunities in Asia.
|
Smart R&D partnerships – how, what, who?
Recognizing the needs of the BioPharma industry, Terrapinn brings together the industry’s best minds from companies like GlaxoSmithKline, Eli Lilly, Roche, Takeda, Merck-Banyu, Advinus, Zydus Cadila and the most promising biotechs and leading research institutes in Asia to Pharma R&D Partnering Asia 2010 to share with you their R&D strategy and the most viable partnership models for Asia.
Be at Pharma R&D Partnering World Asia where international and regional pharmaceutical companies, start-up & spin-off biotechs, research and academic institutions, professional investors, contract research service providers come together to network and evaluate partnering opportunities in Asia.
» More about the programme
» Register for a seat now!
|
Pharma R&D Partnering World Asia is part of |
|
What can you expect at
BioPharma Asia Convention 2010
-
1000+ senior executives
-
500+ exhibitor products
-
160+ speakers
-
70+ exhibitors
-
-
-
-
-
-
» Find out more about the exhibiton
|
|
Brochure is available for download
|
Delegates who are attending any of the four conferences in 2010, namely “Biologic Manufacturing World Asia”, “Pharma R&D Partnering World Asia”, “World Pharma Trials Asia” and “Drug Discovery Technology World Asia”, will be able to gain free access to the joint leadership roundtable session
|
|
Distinguished guest speakers
|
 |
 |
 |
Israel Makov
Chairman, Given Imaging, Chairman, Netafim, Former President and Chief Executive Officer
Teva Pharmaceutical
Industries, Israel |
Villoo Morawala Patell
Founder, Chairperson &
Managing Director
Avesthagen, India
|
Peter M. Kash
President
Riverbank Capital
Securities, USA
|
|
|
|
Confirmed speakers for 2010
|
 Friedrich Nachtmann, Head Biotech Operations,
Sandoz, Austria
|
 David Robinson, Vice President, BioProcess R&D, Merck, USA
|
 Thomas Vanden Boom, Vice President, Global Biologics R&D, Hospira, USA
|
 Rolf Werner, Corporate Senior Vice President, Biopharmaceuticals, Boehringer Ingelheim, Germany
|
 Patrick Farrell, Director Cell Culture, Viral Vaccine BioProcess Research and Development, Sanofi Pasteur, Canada
|
 Simon Green, Senior Vice President, Global R&D Product Development, CSL Australia
|
 Tony Scullion, Senior Vice President-International and New Business Development, Pfizer Inc., USA
|
 Joerg Heidrich, Senior Vice President, Global Head Product Supply Biotech, Berkley Site Head, Bayer HealthCare Pharmaceuticals, USA
|
|
|
|
|
|
